Category: Ophthalmology

Retinal diseases, such as Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME), are major causes of severe vision loss. A key factor driving these conditions is a protein called Vascular Endothelial Growth Factor (VEGF), which triggers abnormal, leaky blood vessel growth. EYLEA® (aflibercept), developed by Regeneron, is a vital biologic therapy designed to …

EYLEA® in Retinal Therapy: Understanding this Key InjectableRead More